Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice

Hepatology

Volumn 56, Issue 5, 2012, Pages 1913-1923

  Hsu, Yu Chen ^a,b   Huang, Hsiang Po ^a   Yu, I Shing ^a   Su, Kang Yi ^b,c   Lin, Shu Rung ^c   Lin, Wei Chou ^a   Wu, Hua Lin ^d   Shi, Guey Yueh ^d   Tao, Mi Hua ^e   Kao, Cheng Heng ^f   Wu, Yao Ming ^a   Martin, Patricia E ^g   Lin, Shih Yao ^h   Yang, Pan Chyr ^a,b,e   Lin, Shu Wha ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^h AbGenomics International Inc   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; GAP JUNCTION PROTEIN; HEPSIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL SIZE; CONTROLLED STUDY; HEMODYNAMICS; HOMEOSTASIS; IN VIVO STUDY; INTRAVITAL MULTIPHOTON MICROSCOPY; LIVER CELL; LIVER SINUSOID; MALE; METASTASIS; MOUSE; MULTIPHOTON MICROSCOPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

ANIMALS; CONNEXINS; HEMODYNAMICS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84868205856     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25773     Document Type: Article

References (34)

1. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008; 320: 1088-1092.
2. Wu Q. Type II transmembrane serine proteases. Curr Top Dev Biol 2003; 54: 167-206.
3. Wu Q, Parry G. Hepsin and prostate cancer. Front Biosci 2007; 12: 5052-5059.
4. Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou SH, Kurachi K. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem 1991; 266: 16948-16953.
5. Torres-Rosado A, O'shea KS, Tsuji A, Chou SH, Kurachi K. Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. Proc Natl Acad Sci U S A 1993; 90: 7181-7185.
6. Kazama Y, Hamamoto T, Foster DC, Kisiel W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 1995; 270: 66-72.
7. Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, et al. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 2005; 390: 125-136.
8. Moran P, Li W, Fan B, Vij R, Eigenbrot C, Kirchhofer D. Pro-urokinase-type plasminogen activator is a substrate for hepsin. J Biol Chem 2006; 281: 30439-30446.
9. Miao J, Mu D, Ergel B, Singavarapu R, Duan Z, Powers S, et al. Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model. Int J Cancer 2008; 123: 2041-2047.
10. Wu Q, Yu D, Post J, Halks-Miller M, Sadler JE, Morser J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J Clin Invest 1998; 101: 321-326.
11. Yu IS, Chen HJ, Lee YS, Huang PH, Lin SR, Tsai TW, Lin SW. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration ability. Thromb Haemost 2000; 84: 865-870.
12. Guipponi M, Tan J, Cannon PZ, Donley L, Crewther P, Clarke M, et al. Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss. Am J Pathol 2007; 171: 608-616.
13. Schliess F, Häussinger D. Osmosensing by integrins in rat liver. Methods Enzymol 2007; 428: 129-144.
14. Blendis LM, Orrego H, Crossley IR, Blake JE, Medline A, Isreal Y. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. HEPATOLOGY 1982; 2: 539-546.
15. Smedsrød B, Le Couteur D, Ikejima K, Jaeschke H, Kawada N, Naito M, et al. Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 2009; 29: 490-501.
16. Li FC, Liu Y, Huang GT, Chiou LL, Liang JH, Sun TL, et al. In vivo dynamic metabolic imaging of obstructive cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1091-G1097.
17. Ewing J. Neoplastic Diseases, 6th ed. Philadelphia, PA: W. B. Saunders; 1928.
18. Quist AP, Rhee SK, Lin H, Lal R. Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 2000; 148: 1063-1074.
19. Kojima T, Spray DC, Kokai Y, Chiba H, Mochizuki Y, Sawada N. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line. Exp Cell Res 2002; 276: 40-51.
20. Plotkin LI, Manolagas SC, Bellido T. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 2002; 277: 8648-8657.
21. Chen CH, Su KY, Tao MH, Lin SW, Su YH, Tsai YC, et al. Decreased expressions of hepsin in human hepatocellular carcinomas. Liver Int 2006; 26: 774-780.
22. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology 1994; 134: 1879-1887.
23. Ikejima K, Watanabe S, Kitamura T, Hirose M, Miyazaki A, Sato N. Hepatocyte growth factor inhibits intercellular communication via gap junctions in rat hepatocytes. Biochem Biophys Res Commun 1995; 214: 440-446.
24. Muramatsu A, Iwai M, Morikawa T, Tanaka S, Mori T, Harada Y, Okanoue T. Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells. Carcinogenesis 2002; 23: 351-358.
25. Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol 2011; 3: S7-S19.
26. Leithe E, Rivedal E. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J Cell Sci 2004; 117: 1211-1220.
27. Traub O, Look J, Paul D, Willecke K. Cyclic adenosine monophosphate stimulates biosynthesis and phosphorylation of the 26 kDa gap junction protein in cultured mouse hepatocytes. Eur J Cell Biol 1987; 43: 48-54.
28. Thomas T, Telford D, Laird DW. Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem 2004; 279: 19157-19168.
29. Laird DW, Puranam KL, Revel JP. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 1991; 273: 67-72.
30. Musil LS, Le AC, VanSlyke JK, Roberts LM. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J Biol Chem 2000; 275: 25207-25215.
31. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293-295.
32. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 2004; 101: 4477-4482.
33. Shibayama Y, Nakata K. The role of sinusoidal stenoses in portal hypertension of liver cirrhosis. J Hepatol 1989; 8: 60-66.
34. Xuan JA, Schneider D, Toy P, Lin R, Newton A, Zhu Y, et al. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res 2006; 66: 3611-3619.